# Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years)

> **NCT00973700** · PHASE3 · COMPLETED · sponsor: **Novartis Vaccines** · enrollment: 784 (actual)

## Conditions studied

- Novel 2009 Influenza H1N1

## Interventions

- **BIOLOGICAL:** MF59-eH1N1_f
- **BIOLOGICAL:** eH1N1_f

## Key facts

- **NCT ID:** NCT00973700
- **Lead sponsor:** Novartis Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2009-10
- **Final completion:** 2010-10
- **Target enrollment:** 784 (ACTUAL)
- **Last updated:** 2015-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00973700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00973700, "Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years)". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00973700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*